Medical

Medical

New PerfectLum 4 with Apple iMac 27” received FDA clearance. This bundle will help medical facilities to meet Quality Assurance Guidelines for diagnostic monitors

Wilmington, DE , September 10, 2020 – QUBYX is releasing a new version of its DICOM calibration and display quality assurance (QA) software PerfectLum with the Apple 5K iMac 27” to the public. The bundle received FDA(510K) clearance and can even be used as a home office workstation.

With this move, QUBYX strengthens its presence in the important diagnostic, teleradiology, and medical display market with a product that will likely under-price most existing FDA approved medical monitors. This is the first Apple iMac diagnostic medical display to be offered to healthcare institutions.

QUBYX’s PerfectLum is a multi-platform, multilingual, full-featured, calibration system with remote management that significantly enhances display performance in all circumstances. More importantly, PerfectLum provides up-to-date industry-specific compliance with medical imaging standards (Including NEMA DICOM part 14 GSDF). This is the first time that such industry-specific standards have been achievable on a Mac.

Apple has a long history of premium performance monitors and the current models are no exception, offering impressive specs – 500nits brightness, 5K with 5120 x 2880 resolution, P3 (wide color) and a billion colors.

“In medical imaging departments, where every effort should be made to maintain the adequate image quality, calibrations and QA procedures have to be done regularly. That requires much time.” – says Marc Leppla, Director of Qubyx. “We believe that the last update of PerfectLum with its convenient features will considerably facilitate the QA procedures for the diagnostic or clinical display users, save time and money.”

Download and try the latest release of PerfectLum with the new functionality at http://qubyx.com/

About Qubyx

Qubyx develops advanced turnkey software solutions used in a number of industries, relying on image quality. With our powerful, easy to handle and cost-saving tools you can always be certain that your devices reproduce colors accurately.

For further details, please contact

Mr. Marc Leppla

QUBYX Medical Solutions Inc.

Wilmington, DE

USA

30 Years of The Hilditch Group – The Premiere Medical Auctioneer in Britain

[ad_1]

The Hilditch Group celebrate its 30th anniversary this Summer, making it the longest running medical equipment auctioneer in Britain. Established in June 1990 by Mike and Nicky Hilditch, it has grown to be the largest auctioneer of healthcare equipment in Europe and a key partner to the majority of NHS trusts in the UK, working as a sales agent on their behalf to maximise asset value for the sale and removal of all medical assets.

Working as a freelance auctioneer in the UK and South Africa, Mike was struck that the standards of professionalism varied considerably across auction houses. In essence anyone can call themselves an auctioneer with no formal training and no qualifications, leading to a disparity between companies and the level of service that they offered. Mike and Nicky made it their aim to establish the most professionally managed commercial auction house in the UK. An accomplishment that they have undoubtably achieved, with professionalism being very much at the heart of the company’s ethos today. The organisation was originally set up as a general and commercial salesroom; offering sales in plant and machinery, general household and antiques and commercial catering equipment. In the early days the organisation even held sales in horses, a throwback from Mike’s days working in livestock auctions. Starting with a modest 5 staff members, this quickly grew to 8 in the first year and now employs almost 50.

It was during the second year whilst clearing a kitchen for a local hospital that Mike noticed whilst the hospital was happy to sell the catering equipment, they would, however, not permit the sale of redundant surgical trolleys, instead these were simply thrown into a skip. From that moment the seed of an idea was planted and the Hilditch Group started researching the medical market. At that time the majority of hospitals disposed of all their medical equipment, regardless of condition, due to a general fear of liability. It took several years for Hilditch as an organisation to persuade a handful of hospitals to consider the resale of their redundant medical equipment as an option. The equipment was sold to a large number of overseas buyers, who normally would not have been able to afford new equipment. Most of these buyers are still trusted customers today. As a result, huge quantities of equipment were given an extended life, landfill and recycling was reduced. These days the reasons for resale of medical equipment have taken on even more pertinence as we are all much more aware of the waste in our society. The expansion of the company was initially slow as NHS trusts took a long time to consider the implications of resale. The introduction of the WEEE (Waste Electrical and Electronic Equipment) legislation sped the process up, as hospitals considered how they could reduce waste and fulfil their obligations.

Many new hospitals were built over subsequent years as part of the PFI initiative, which resulted in large numbers of redundant assets being surplus to requirements. The Hilditch Group was invited to work with the Department of Health to promote the re-use of equipment as part of the NHS’ waste management strategy. As the Hilditch Group offers a complete site clearance service they manage the sale and disposal of the entire contents of old hospital sites and with a fleet of their own vehicles and experienced drivers, the Hilditch Group can clear medical equipment from a site of any size.

Innovation has always been key to the company’s success, they were one of the first auction houses to offer Timed Online Auctions, developing their own bidding system years before any other auctioneers. Mike also was involved in establishing the National Association of Auctioneers and Valuers (NAVA), an organisation dedicated to improving the professional status of auctioneers and upholding the highest standards of service delivery. Now a Fellow of the Association, he is very keen that his valuers take the NAVA exams and carry out regular CPD courses to improve their skills.

The Hilditch Group have continued to innovate and add customer value over the decades including the addition of the in-house medical engineering department around 20 years ago. The qualified and accredited medical engineering staff have extensive experience and provide a wide range medical engineering services and support for both on and off-site requirements, including: long term maintenance of medical equipment, with planned preventative maintenance contracts (PPMC’s), equipment testing and condition reporting, inventories and assessments, and medical decontamination.

In the past 10 years the company has grown exponentially, expanding its customer base to include, not only most of the public and hospitals, but also manufacturers, banks and lease companies. The organisation has expanded into western Europe with offices in Spain (Hilditch Iberia), France and Germany. This growth does not seem to be slowing down either as the Hilditch Group now has over 20,000 registered buyers from 182 different countries, and can guarantee the largest number of buyers for your redundant medical equipment. With around 30 individual auctions and over 2,000 lots of high-quality used and ex-demonstration items per month. the Hilditch Group is the foremost authority in the market for the re-sale of bio-medical devices, helping clients generate revenue and release equity from old equipment.

The Hilditch Group has also created a medical asset valuation tool in a software-as-a-service solution for those managing end of life values for a large number of medical assets, such as lease companies and large private hospitals.

No other medical device asset manager has such and extensive range of services for your health care establishment; the Hilditch Group remains the premiere medical equipment auctioneer in the United Kingdom. To find out more about our services or to discover how the Hilditch Group can facilitate the resale of your used medical equipment, visit our website to find out more: www.hilditchgroup.com

Source link

LG Electronics selects QUBYX PerfectLum for its medical displays and has received FDA clearance for the bundle.

[ad_1]

Wilmington,DE, June 24, 2020

Today QUBYX Medical Solutions Inc. announced that LG Electronics selected QUBYX PerfectLum to be bundled with LG medical displays. LG has received FDA 510(K) clearance for the bundle, which will be available immediately.

This combination is the perfect solution for all professionals in the medical field; in particular radiologist, chiropractors, urgent care facilities, hospitals, medical clinics, and all teleradiology providers.

LG Electronics will sell and provide software support for three monitors: The 27-inch 8MP clinical review medical display (27HJ713C-B), the 32-inch 8MP diagnostic display (32HL512D-B), and the 21.3-inch 3MP diagnostic monitor (21HK512D-B)

These displays will now be fully compliant with: Digital Imaging and Communications in Medicine (DICOM) Part 14. LG’s 21HK512D and 32HL512D models have FDA 510(k) Class II approval, and the 27HJ713C model is FDA registered.

Stephen K. Hu, head of medical monitors for LG Business Solutions USA, said:

“As demand for remote healthcare services grows, diagnostic displays will play a crucial role in disciplines such as teleradiology. Together with QUBYX, LG is committed to developing new solutions for healthcare professionals to help them provide the best possible healthcare services.”

QUBYX’s PerfectLum is a multi-platform, multilingual, full-featured quality assurance tool, with a remote management and cloud solution, that not only calibrates a primary or secondary medical display, but also performs acceptance and constancy tests to verify that displays consistently conform to international regulations including: NEMA DICOM part 14, GSDF, AAPM TG-18, DIN 6868-57, DIN 6868-157, JESRA X-0093, IEC 62563-1 ACR and NYS/NYC Primary Diagnostic Monitor guidelines (NY PDM).

The PerfectLum Suite is the preferred medical display calibration and quality control solution used by hospitals, teleradiology companies, university health departments, and other medical facilities, worldwide. Integration of PerfectLum with the new LG medical displays, creates a perfect pairing as LG Electronics has the scale, infrastructure, and reputation to assure all users of a superior product and user experience.

Marc Leppla, CTO at QUBYX, said:

“Based on early interest, we expect these displays to become a standard-bearer for all teleradiologists, and are extremely happy that LG recognized the versatility, precision, and accuracy of the PerfectLum system and sees it as the perfect calibration complement for LG medical displays.”

About QUBYX

QUBYX is a software/hardware manufacturer providing new dimensions of image quality in the medical imaging industry and display calibration field.

For more information, visit: https://qubyx.com

Press Contact:

Marc Leppa CTO

QUBYX Medical Solutions Inc.

Source link

AngelMD Adds Executive Medical Director to Senior Leadership Team

[ad_1]

AngelMD is proud to announce the addition of a clinician-entrepreneur-investor to the ranks of its growing leadership team. Murdoc Khaleghi, MD, MBA has stepped into the role of Executive Medical Director and will focus on physician engagement/education and investment analysis.

“Dr. Khaleghi is the perfect addition to the team. His entrepreneurial and investing experience, while also having been a physician and hospital leader, give him a perspective that ensures we are effectively working with physicians and health systems to evaluate and advise ventures.” said Tobin Arthur, CEO AngelMD.

Murdoc Khaleghi, MD, MBA is an Emergency Medicine physician who has co-founded and/or served as Founding Medical Director/Chief Medical Officer of several life science and health technology ventures including StemoniX, EverlyWell, WellnessFX, and others. After years of angel investing, more recently he has led the Life Science investing cohort of Rockies Venture Club, one of the largest in the country. He has also served as President/CEO of Westfield Emergency Physicians and Chief Medical Information Office of Baystate Noble Hospital. Dr. Khaleghi has degrees in medicine, bioengineering, and business, from Columbia University, UC Berkeley, and UC San Diego.

The heart of the AngelMD network has been physicians, dentists, and scientists, and has developed clinician talent on the management team to optimize network growth and engagement. Physician members of the AngelMD community help source, evaluate and advise companies to create company and physician success.

About AngelMD
AngelMD — an online Healthcare Investment and Innovation Marketplace — connects and engages a network of healthcare providers and subject matter experts, angel and institutional investors and private healthcare companies through a technology platform to create better outcomes for investors, entrepreneurs and patients. For more information, visit https://www.angelmd.co

Source link

NEW! Rejuv Medical Moves To Edina, MN

[ad_1]

Innovative Healthcare | Lasting Change

Edina, MN Rejuv Medical today announced their second clinic location has moved to Edina, MN. This milestone is a major move for Rejuv Medical on its mission to restoring health worldwide.

“This area has been a prominent healthcare community for years. Our new location is conveniently located near a major Twin Cities highway, with hotels, retail shopping stores and restaurants within walking distance. We are proud to be joining this community and believe Rejuv Medical will be a perfect fit.” Says Chad Rusch – COO at Rejuv Medical.

This news comes in the wake of many recent initiatives and accomplishments of the company, including:
• #1 Regenerative Clinic in the Regenexx Network for 2017, 2018 and 2019
• HEALTHOVATE with DRB, the DRB Show featured on Kare11
• Voted Best Specialty Doctor in the Central MN Area multiple years.

To learn more about the new Rejuv Medical, click here.

About Rejuv Medical: Our mission is to restore health worldwide. We do this by restoring the body through evidence based treatments that reverse the impact of disease and degeneration, without prescription drugs or surgery. Our whole healthcare approach incorporates regenerative and functional medicine, physical therapy, primary care, nutrition and fitness to bring about lasting and balanced health and wellness.

Source link

Brains Bioceutical to provide EU-GMP CBD API for Brazils first medical approved cannabis product

[ad_1]

https://www.prfire.com/

Brains Bioceutical Corp (“BRAINS” or the “Company”)(Vancouver, Canada), a global leader in pharmaceutical, wellness and veterinary cannabidiol (CBD) based Active Pharmaceutical Ingredient (API) production, is proud to announce its landmark accomplishment to bring Brazil’s first registered medical cannabis product under the new regulations that ANVISA put in place in December of 2019, Brains EU-GMP CBD API to the Brazilian market.

“Our partners in Brazil are a global leader in pharmaceutical production and clinical trials. I’m very proud of this historic moment, wherein we have combined our strengths to create the first registered product under the new regime. The standard we have set for the purity of our CBD is second to none. The team of world-renowned scientists and executives at Brains, continue to achieve landmark milestones with a relentless pursuit of historic firsts in the CBD industry. We look forward to monetizing and capitalizing on the resulting market opportunities that this launch will propel us towards. We now have registered CBD product in the epicenter of the European continent within the UK, and supply the CBD material to our South American partner for achieving the first registered cannabis product under the new ANVIA regulations in Brazil.” said Rick Brar, Chairman and CEO of Brains Bioceutical Corp.

Brains South American partner is a leader in the global pharmaceutical industry. Producing approximately 11.5 billion therapeutic doses per year, and has more than 4,200 employees. The company has one of the largest portfolios of generic drugs in Brazil, and supplies both South American and global markets. Since the recent announcement in December 2019, this is the first registered cannabis product under the special category created by ANVISA. We will be able to export Brains EU-GMP CBD API from the UK for our partner in Brazil to formulate their products to be sold in pharmacies and distributors in Brazil and potentially expand that to the rest of South America as the marketplace expands. All of our partners formulations adhere to the highest quality for manufacturing and testing with a view to making it the safest product available in the region. Under the terms of the agreement, Brains will provide its EU-GMP, CBD API to be used in the registered cannabis products.

“Now more than ever, it is important that patients have access to products that do not compromise on safety and quality. We believe that these products are bringing forward the highest quality product into South America. The Brains industry leading regulatory team was able to introduce the first cannabinoid based specials products in the UK and the first to supply our EU-GMP API ingredient to our partner in Brazil. Brains CBD is one of the few natural, plant-based API ingredients available anywhere on the planet. This team will successfully lead Brains to another first later this year, when we spearhead the reshaping of the CBD industry in the UK by taking the same approach for our Novel Foods application,” added Gurdeep Bains, President of Brains.

Since 2014, Brains subsidiary, BSPG Laboratories, has been a leader in clinical stage, natural source, cannabinoid manufacturing located in Sandwich, Kent, United Kingdom. Brains presently has Medicines and Healthcare Products Regulatory Agency’s (MHRA) approval to manufacture an approved pharmaceutical grade ingredient (API) for the global pharmaceutical industry. Having shipped over 100 kilos to Brazil over the past year, Brains has been providing patients in Brazil with reliable access for over 2 years.

About Brains Bioceutical Corp
Brains Bioceutical Corp is a leader in GMP – certified production of naturally sourced active pharmaceutical ingredients (APIs) for the pharmaceutical and nutraceutical industries. Brains Bioceutical is one of the only natural plant-based cannabinoid active pharmaceutical ingredient (API) manufacturers in commercial production today and is involved in academic and clinical trials across the globe.

Brains Bioceutical Corp. Senior Management Team is made up of a rare hybrid of pharmaceutical and consumer goods executives-having held C-suite and other senior positions with companies such as GW Pharma, Merck, Seattle Seahawks, Golden State Warriors, Danone, Earthbound Farms, International Herbs, Cascadia Specialties and The Royal British Navy. This experience allows Brains to execute at a hyper-efficient level in the pharma and wellness categories.

Brains’ wholly owned subsidiary in the UK, BSPG Laboratories is one of only nine companies that has the commercial capability and EudraGMDP certification to produce CBD API, and is only one of four worldwide to source a natural plant based cannabidiol. Brains is currently manufacturing a line of phytocannabinoid THC-free CBD API products.

MHRA Registered API: Inspected and Registered with the MHRA (Medicines and Healthcare Products Regulatory Agency).

API Certificate Number: UK API 48727

SOURCE: http://www.in.gov.br/web/dou/-/resolucao-re-n-1.186-de-20-de-abril-de-2020-253341253

For further information, please contact:
Calvin Rasode, Director of Marketing
Telephone: 1-855-927-2476
Email: calvin@brainsbio.com
Website: www.brainsbio.com

CAUTIONARY STATEMENT:
This news release contains forward looking statements or forward-looking information (“forward-looking statements”) within the meaning of securities laws. Often, but not always, forward looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. All statements, other than statements of historical fact, in this news release are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance are not statements of historical fact and may be forward-looking statements. Risks, uncertainties and other factors involved with forward-looking statements could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Although the Company believes that the assumptions and factors used in preparing the forward-looking statements in this news release are reasonable, there can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

 

Source link

COVID-19 sucks, but charity record don’t need to… in aid of NHS’s Royal Medical Benevolent Fund

[ad_1]

Released on Monday (6th April 2020 ) was a charity record in aid of the Royal Medical Benevolent Fund – a charity who support medical staff and their families in a time of crisis. This is a time of crisis.

The song; Home (City of Dreaming Spires) was recorded by #1 producer George Shilling, who has worked with the likes of Blur, Frank Turner, Yazz, Teenage Fanclub, and Suede’s Bernard Butler. It is written and performed by the Oxford based 3-piece band ‘The Ideas’.

The video features a live recording of the band from their separate homes, in current COVID-19 isolation.

The lyrics, although written last year, are uncanny in their representation of the current circumstances, “Take me to Rome, take me anywhere, just take me home. From the city on fire, to the City of Dreaming Spires, take me home…” – “You can’t run, from the places you love, no matter how obscene, or how serene…”
All proceeds from this incredibly uplifting record will go
directly to the charity.

The Ideas, wear their influences on their sleeves, with obvious references to other Oxford bands like ‘Ride’ and ‘Radiohead’, as well as other notable rockers like ‘The National’ and ‘David Bowie’.

The band said “We’re so happy to be able to help this great charity. Many of us are at home feeling helpless, we just wanted to get up off the sofa and do something…

Both the Ideas and the Royal Medical Benevolent Fund ask for as many people as possible to share this charity release online as possible to enable them to raise important funds at this time.

It is a fantastic record and a fantastic cause.

https://www.youtube.com/watch?v=vjP2T58-BGI?feature=oembed

The UK’s doctors and even medical students will be in dire need of support, during and after the COVID-19 outbreak. They are on the frontline saving lives, whilst potentially risking their own.

Please share content about this record where possible – thank you, it is appreciated. Help us make this uplifting record the soundtrack of 2020. Remember: COVID-19 sucks, but charity records don’t have to…

The Royal Medical Benevolent Fund was formed in 1836. Their Patron is Her Majesty The Queen. Find out more via https://rmbf.org/about

The Ideas are from Oxford. They are Gary S Creigh, Steve Hare and Nick Aspey. Find them on social media via @theideasband or at www.covidsucks.co.uk

Contact Details
Claire Arnott
carnott@rmbf.org
Or, press@covidsucks.co.uk
Media enquiries via 07527317245

Source link

LaingBuisson launches IMTJ Medical Travel Summit and Awards 2020

[ad_1]

Industry-leading event heads for Madrid, September 22-24, 2020 … bringing together key opinion leaders and senior executives to explore the future of the developing medical travel sector

The IMTJ Medical Travel Summit 2020 will take place in Madrid, Spain from September 22nd to 24th 2020 at the Hotel Elba Madrid Alcalá.

LaingBuisson, a UK based provider of market intelligence, consulting, data solutions and patient acquisition to international healthcare businesses has teamed with Temos International for a second year. Temos is the only worldwide independent accreditation body focused on the quality of international patient management from the medical and non-clinical perspectives.

Now in its sixth year, the Summit will bring together industry leaders to share their knowledge and experience and ensure the long-term development of this industry.

The event in Madrid combines four key elements:

• The IMTJ Medical Travel Summit brings together key opinion leaders and senior executives involved in medical travel and healthcare businesses across the world.
• The IMTJ Medical Travel Awards celebrate the success of the leading players in medical travel and health tourism.
• The IMTJ Marketplace provides exhibitors with a great opportunity to meet new customers.
• B2B Meetings bring together buyers of medical travel and international patient services with providers and suppliers who are seeking new business opportunities and sources of patient referral.
• The IMTJ Academic Conference provides a rare opportunity for academics and researchers from around the globe to share their knowledge and research into this developing sector.

Earlybird rates are available now. Reduced rates are on offer for delegates from academic and research institutions.

For all media enquiries please contact Sarah Ward: sarahward@imtj.com.

About LaingBuisson and IMTJ

LaingBuisson has been serving clients for over 30 years with market, policy and strategy insights, data and analysis across healthcare and social care. We are the chosen provider of independent sector healthcare market data to the UK Government’s Office for National Statistics and work globally with providers, commissioners, payors, manufacturers, investors, regulators and advisors. We help our clients to understand their markets, make informed decisions and deliver better outcomes through market intelligence, consulting and data solutions.

LaingBuisson publishes the International Medical Travel Journal  which provides insight into the medical travel and medical tourism sector. IMTJ was established in 2007 in response to the increasing interest in medical travel and cross border healthcare. It embraces many of the themes that challenge healthcare providers across the world – insurance, accreditation, marketing and promotion, quality, patient safety, levels of care and experience in treating international patients.

About Temos International

Founded in 2010, Temos International Healthcare Accreditation is the only worldwide independent accreditation body focused on the quality of international patient management from the medical and non-clinical perspectives. With regional offices spread around the world, the German-based Temos International serves providers and patients on six continents.

Temos helps hospitals, clinics and medical travel coordinators to find their highest levels of performance to deliver top quality for the international patients and medical travelers they serve and to continuously take care of their quality. By working collaboratively, Temos International encourages innovation and avoid the “one size fits” all approach to accreditation which does not work across cultures for providers or patients. With its deep understanding of universal standards of quality and cultural differences in expectations around the patient experience, Temos raises clinical standards, improve clinical and non-clinical outcomes as well as patient safety, and reduces costs for overall client satisfaction.

Source link

Success in medical travel recognised by IMTJ Medical Travel Awards 2019

[ad_1]

Success in medical travel recognised by IMTJ Medical Travel Awards 2019

The very best in the medical travel sector are celebrating following the announcement of the winners in the IMTJ Medical Travel Awards 2019.

The awards celebrate innovation and excellence in the medical travel, medical tourism and health tourism industry. Unlike other awards in the sector, the IMTJ awards are judged by an independent panel of medical travel experts, chaired by IMTJ Editor in Chief, Keith Pollard.

The awards were presented on 2 December at a high-profile reception in Berlin, Germany during the IMTJ Medical Travel Summit which brought together leading healthcare providers and medical tourism experts from around the world. The Awards were generously sponsored by Medical Korea.

The 2019 winners are:

Best quality initiative: Thomson Hospital Kota Damansara
Excellence in customer service: Clemenceau Medical Center in affiliation with Johns Hopkins Medicine International
Best marketing initiative: China Medical University Hospital
Best medical travel web site: Korea Health Industry Development Institute
Medical travel agency of the year: Right Choice Home & Away
Best use of technology in medical tourism: Dental Holiday by Smile Clinic
International cosmetic surgery clinic of the year: Bagatin Clinic
International dental clinic of the year: FMS Dental Hospitals
International fertility clinic of the year: TMC Fertility
International cancer centre of the year: Apollo Speciality Cancer Hospital – Chennai
International eye clinic of the year: Hangil Eye Hospital
International hair clinic of the year: Advanced Hair Clinics
Specialist international patient centre: China Medical University Hospital
International hospital of the Year: Centro Médico Teknon, Grupo Quirónsalud
Sanjiv Malik Lifetime Achievement: Dr Prathap C. Reddy
Health and medical tourism: Cluster of the year: Malaysia Healthcare Travel Council
Health and medical tourism: Destination of the year: Korea Health Industry Development Institute

Editor in Chief of IMTJ, Keith Pollard says:

“The IMTJ Medical Travel Awards 2019 demonstrated the progress that is being made in the medical travel, medical tourism and health tourism industry. The standard of entries was outstanding and highlighted how providers are raising their game and demonstrating their innovation, excellence, and best practices. Combining an exceptional customer experience with the best possible medical outcomes is never easy, but our Award winners demonstrate what is possible. I’m looking forward to a bumper entry for next year’s IMTJ awards, and I encourage other hospitals, clinics and medical travel providers to raise their game to match or even better this year’s winners.”

For all media enquiries, including images of the ceremony, contacts for winners and interviews with Keith Pollard, please contact Sarah Ward: sarahward@imtj.com

About IMTJ

The International Medical Travel Journal provides insight into the medical travel and medical tourism sector. IMTJ was established in 2007 in response to the increasing interest in medical travel and medical tourism. It embraces many of the themes that challenge healthcare providers across the world – insurance, accreditation, marketing and promotion, quality, patient safety, levels of care and experience in treating international patients.

IMTJ is independent of the associations and special interest groups that have come aboard the medical tourism bandwagon. Our aim is to create a central focus for information, resources and opinion on medical travel for those involved in the industry, anywhere in the world.

The internationalisation of healthcare through health tourism is at the heart of IMTJ. Patients are becoming healthcare consumers and in many countries, patient choice is being extended to surgery and treatment provided by international hospitals and clinics. By sharing expertise, knowledge, and views about the health travel industry, IMTJ helps to ensure that patient expectations are met, and that the industry maintains a high reputation.

The International Medical Travel Journal (IMTJ) is owned and managed by LaingBuisson. The company also operates a consumer facing portal for medical tourism – Treatment Abroad.

Media Contact Details
Sarah Ward, IMTJ
BERKHAMSTED, HERTS
01442817817
sarahward@imtj.com

Source link

A truly international audience came to Berlin to debate the future of medical travel

[ad_1]

A truly international audience came to Berlin to debate the future of medical travel

The IMTJ Medical Travel Summit 2019 , held in Berlin, Germany on December 1-3 2019, attracted delegates, exhibitors, sponsors and participants from throughout Europe and as far afield as Taiwan, Japan, Korea, Malaysia, India, UAE, Mexico and USA. The Summit brought together key opinion leaders and senior executives involved in medical tourism and healthcare businesses across the world to discuss the future of this developing industry sector.

The Summit was co-hosted by TEMOS

The Summit addressed many of the issues that face the sector – the future of global healthcare, trends in healthcare and technology, destination development, and the patient experience. Sessions were dedicated to specific areas such as fertility travel, dental travel, and wellness tourism and important international patient markets including Russia and the CIS, and the Gulf. The closing highlight of the event, the Great Debate, conducted in Oxford Union style, considered whether “medical travel facilitators are an endangered species – arguments for and against.”

According to Keith Pollard, IMTJ Editor in Chief and Executive Chairman of LaingBuisson International:

“Without doubt, this year’s IMTJ Medical Travel Summit was the best so far. We welcomed back many regular attendees who view the Summit as the “must attend” event in their calendar. First timers were impressed by the quality of the content and the networking opportunities and will certainly be back for more next year.“

The event was made possible through the support of Medical Korea, Health Care Industries Cluster Berlin-Brandenburg Health Capital, Bagatin Clinic, Kvarner Health Croatia, Quironsalud, Sana Hospital Group, Gruppo San Donato, Curemart, Healthcare Markets International, European Patient Experience Innovation Congress, Malaysia Healthcare, Illes Balears, Western Union Business Solutions, Mayo Clinic Healthcare in partnership with Oxford University Clinic, Temos International, Clemenceau Medical Center, Health Tourism Albania, Thornbury Nursing Services, France Surgery, Sant Joan de Déu-Barcelona Children’s Hospital, Costa Cálida – Región de Murcia, Helios International, Dünyagöz Hospitals Group, China Medical University Hospital.

For all media enquiries, including images of the Summit and interviews with Keith Pollard, please contact Sarah Ward: sarahward@imtj.com

About IMTJ

The International Medical Travel Journal provides insight into the medical travel and medical tourism sector. IMTJ was established in 2007 in response to the increasing interest in medical travel and medical tourism. It embraces many of the themes that challenge healthcare providers across the world – insurance, accreditation, marketing and promotion, quality, patient safety, levels of care and experience in treating international patients.

IMTJ is independent of the associations and special interest groups that have come aboard the medical tourism bandwagon. Our aim is to create a central focus for information, resources and opinion on medical travel for those involved in the industry, anywhere in the world.

The internationalisation of healthcare through medical travel is at the heart of IMTJ. Patients are becoming healthcare consumers and in many countries, patient choice is being extended to surgery and treatment provided by international hospitals and clinics. By sharing expertise, knowledge, and views about the health travel industry, IMTJ helps to ensure that patient expectations are met, and that the industry maintains a high reputation.

LaingBuisson

The International Medical Travel Journal (IMTJ) is owned and managed by LaingBuisson International. The company also operates consumer facing portals for medical tourism – Treatment Abroad and Fertility Treatment Abroad.

LaingBuisson is a leading healthcare intelligence provider and has been serving clients for over 30 years with insights, data and analysis of market structures, policy and strategy across healthcare and social care. LaingBuisson is the chosen provider of independent sector healthcare market data to the UK Government Office for National Statistics and works globally with providers, commissioners, payors, manufacturers, investors, regulators and advisors. LaingBuisson helps clients to understand their markets, make informed decisions and deliver better outcomes through market intelligence, consulting and data solutions.

Source link